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Abstract: 
Rationale, aims and objectives: Timely switching from intravenous to oral 
therapy ensures optimised treatment and efficient use of healthcare 
resources. Intravenous (IV) paracetamol is widely used for postoperative 
pain management but not always switched to the oral form in a timely 
manner, leading to unnecessary increase in expenditure. This study aims 
to evaluate the impact of a multifaceted intervention to promote timely 
switching from the IV to oral form in the postoperative setting.  
Methods: An evidence-based prescribing protocol was designed and 
implemented by the clinical pharmacy team in a single district general 
hospital in Egypt. The protocol specified the criteria for appropriate 
prescribing of IV paracetamol. Physicians were provided with information 
and educational sessions prior to implementation. A prospective, quasi-
experimental study was undertaken to evaluate its impact on IV 
paracetamol utlisation and costs. Data on monthly utilisation and costs 
were recorded for 12 months before and after implementation (January 
2012 to December 2013). Data were analysed using interrupted time 
series analysis.    
Results: Prior to implementation, in 2012, total spending on IV 
paracetamol was 674,154 Egyptian Pounds (L.E.) ($236,68). There was a 
non-significant (p>0.05) downward trend in utilisation (-32 
ampoules/month) and costs (reduction of 632 L.E. ($222)/month). 
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Following implementation, immediate decrease in utilization and costs 
(p<0.05) and a trend change over the follow-up period were observed. 
Average monthly reduction was 26% (95% CI: -24% to -28%, p <0.001).  
Conclusion: A multifaceted, protocol-based intervention to ensure timely 
switching from IV-to-oral paracetamol achieved significant reduction in 
utilisation and cost of IV paracetamol.  
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Abstract 
Rationale, aims and objectives: Timely switching from intravenous to oral therapy ensures 
optimised treatment and efficient use of healthcare resources. Intravenous (IV) paracetamol is 
widely used for postoperative pain management but not always switched to the oral form in a 
timely manner, leading to unnecessary increase in expenditure. This study aims to evaluate 
the impact of a multifaceted intervention to promote timely switching from the IV to oral 
form in the postoperative setting. 
Methods: An evidence-based prescribing protocol was designed and implemented by the 
clinical pharmacy team in a single district general hospital in Egypt. The protocol specified 
the criteria for appropriate prescribing of IV paracetamol. Physicians were provided with 
information and educational sessions prior to implementation. A prospective, quasi-
experimental study was undertaken to evaluate its impact on IV paracetamol utlisation and 
costs. Data on monthly utilisation and costs were recorded for 12 months before and after 
implementation (January 2012 to December 2013). Data were analysed using interrupted time 
series analysis.   
Results: Prior to implementation, in 2012, total spending on IV paracetamol was 674,154 
Egyptian Pounds (L.E.) ($236,68). There was a non-significant (p>0.05) downward trend in 
utilisation (-32 ampoules/month) and costs (reduction of 632 L.E. ($222)/month). Following 
implementation, immediate decrease in utilization and costs (p<0.05) and a trend change over 
the follow-up period were observed. Average monthly reduction was 26% (95% CI: -24% to 
-28%, p <0.001).  
Conclusion: A multifaceted, protocol-based intervention to ensure timely switching from IV-
to-oral paracetamol achieved significant reduction in utilisation and cost of IV paracetamol.  
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Introduction 
In the current health care spending landscape, where demand is increasing and resources are 
limited, it is essential that hospitals implement evidence-based policies for the utilisation of 
drugs[1]. The choice of the appropriate route of administration and dosage form is an 
important step in the prescribing of medicines to achieve optimised outcomes from the 
limited drugs’ budget [2,3]. Given the differential pricing of the medicines’ formulations, it is 
important that the choice between these is guided by evidence regarding cost-effectiveness. 
For example, in the context of operative and intensive care, the choice of the intravenous 
route when the oral route is possible or a nasogastric tube is being used would not be 
appropriate [4]. 
Hospitalised patients often begin to receive their medications intravenously when acutely ill 
or postoperatively. However, they are not usually switched to the oral medication in a timely 
manner (i.e. when they become stable and start taking oral medications or diet).5 Clinical 
guidelines on acute pain management in adults in the USA and France recommend oral 
administration of drugs as soon as patients can take them [6,7]. Hence, interventions have 
been developed and implemented to ensure timely switching from the intravenous to the oral 
route in the post-operative administration of drugs. For example, Colombet et al. 
implemented an intervention to promote early switching from IV to oral proton pump 
inhibitors (PPIs) following a sharp increase in the utilization and associated costs of IV forms 
of PPIs. The intervention was successful in reducing the utilization of IV PPIs, although in 
the long run this change was not sustainable [8]. Ripouteau et al. applied a multifaceted 
intervention to promote early switching from IV to oral administration of paracetamol for 
pain management [7]. Their findings showed that nurses erroneously believed that IV 
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paracetamol was more effective and were not aware of the much higher costs associated with 
its use. 
The safety, tolerability and non-sedating effect of paracetamol have been considered the main 
advantages of this medication, although how safe paracetamol is has been recently disputed 
[9]. It is available in the market as oral, rectal and IV preparations. The IV preparation (10 
mg/ml solution for infusion) has been available to the European market since 2002 and was 
introduced to the Egyptian market immediately after the European approval. In 2010 it was 
marketed in the USA. Oral paracetamol is a simple well-tolerated analgesic; but if 
meaningful early plasma concentrations are required, a more generous loading dose is needed 
[10].The IV form is successful in achieving rapid therapeutic concentrations that can 
subsequently be maintained by oral absorption [11,12]. 
Oral dosage forms have several advantages compared to IV, including: lower cost, less 
administration time by nursing staff with lower risk of infection, and increased patient 
comfort and safety through eliminating the requirement for intravenous catheters [13]. Prior 
research in the setting of community-acquired pneumonia has demonstrated that an early IV-
to- Per Oral (PO) switch of medications can also shorten the duration of hospitalization 
[14,15]. 
In Egyptian hospitals the absence of electronic drug-ordering systems - which would enable a 
central computer to provide a daily list of all patients who are on IV paracetamol for long 
periods (and are therefore potential candidates for an IV-to-PO switch) - greatly reduces the 
number of patients who are switched in a timely manner. This represents a considerable 
waste in a health system that is already struggling to provide basic health care due to its 
limited resources. 
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Hence, we developed a multifaceted, protocol-based intervention to increase the efficiency of 
postoperative pain management by identifying patients who are suitable candidates for IV-to-
PO switching and promptly implementing the switch. The aims of this pilot study were: to 
assess the impact this multifaceted, protocol-based intervention on the utilization and cost of 
IV paracetamol and to assess the feasibility of the protocol implementation and its 
acceptability among physicians, with the aim of generating evidence to inform national 
guideline development and implementation. 
Methods 
This is a prospective, quasi-experimental study; where data were collected before and after 
the implementation of this non-computerized protocol. The effect of this protocol on the 
utilisation and costs of IV paracetamol was assessed using interrupted time series analysis. 
1. Setting 
The intervention was implemented in a single district general hospital in the Egyptian capital, 
Cairo. The hospital, which has140 beds, is covered by 22 specialties. The average number of 
surgeries per month is around 400, performed by 17 of the 22 specialties. 
2. Standard procedures for pain management prior to the intervention: 
The standard procedure for postoperative pain management in the hospital was to use IV 
paracetamol immediately after surgery and to maintain it as long as the patient reported 
feeling pain or until discharge. Ideally, patients would then be switched to oral paracetamol 
when they are able to take oral medications. However, this was not usually done in a timely 
manner. 
3. Intervention design and implementation: 
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The general approach was to develop, implement and assess the impact of the intervention. 
The drugs and therapeutics committee (DTC) oversaw the approval, development and 
implementation of the protocol. The process involved the following stages: 
3.1. Defining the criteria for IV paracetamol prescribing: 
In accordance with the nature of the hospital, a general hospital with multispecialty, it was 
necessary to tailor a list suitable to the nature of the hospital patients. This list was 
developed based on published guidelines and specified that IV paracetamol can be 
prescribed: 
o for surgical patients within 48 hours post-operatively; 
o for null-per-oral (NPO) patients or patients with mucositis suffering from pain; 
o for other pain patients only after the approval of the DTC chairman or the pain 
management team;  
o in acutely febrile patients (temperature > 38°C), where one single dose of IV 
paracetamol is recommended, followed by oral form if a regular regimen is 
required; and 
o to patient with erratic gastric absorptions. 
3.2. Designing the IV-to-PO switching protocol 
The main steps of the protocol are summarized in Figure 1 which illustrates the steps involved in 
the process. 
Insert Figure 1 here 
3.3. Revision and approval of the protocol 
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The protocol was presented to both the pain management team and the DTC for revision 
and approval to ensure local consensus and physician buy-in.  
3.4. Pharmacists training 
All the ward pharmacists in the hospital received written orientation about the inclusion 
criteria and on-the-job training on the implementation of the protocol. 
3.5. Physician orientation 
A 10 minutes session was designed to be delivered to the physicians. These sessions were 
delivered by the pharmacy team. Also, electronic messages (via E-mails and SMS) were sent 
to all the physicians via the hospital medical council to inform them about the new protocol 
and the date it was due to come into effect. 
3.6. Official implementation of the protocol 
The approved protocol was officially launched on the 1st of January 2013. From this date, 
all the medication sheets were screened by the ward pharmacists twice daily before 
dispensing doses (10 am dose and 10 pm dose) to ensure that the policy was being 
implemented. 
4. Data collection and analysis 
In order to assess the change in the utilisation of IV paracetamol, data on the number of IV 
ampoules consumed for the whole hospital were determined by the hospital pharmacy on a 
monthly basis over one year, from the 1st January 2013 to 31st December 2013. Data for the 
pre-implementation phase were extracted from the hospital pharmacy’s dispensing records 
for an equivalent period of time directly preceding the implementation of the intervention (1
st
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January 2012 to 31
st
 December 2012). Costs of IV paracetamol were calculated by 
multiplying the number of dispensed ampoules by their unit cost (19.5 L.E. ($6.85). 
Paired sample t-test was used to assess the significance of the change in monthly utilisation 
and costs before and after the intervention. Statistical significance was set at p < 0.05. The 
time series (12 points before and 12 points after the intervention implementation) was 
analysed using Interrupted Time Series (ITS) analysis. Autoregressive, Integrated, Moving 
Average (ARIMA) models were used to analyse associations between observations in the 
pre-intervention series [16,17]. The outcome of this analysis satisfied the assumptions of the 
general linear regression model; hence, a segmented regression model including time and 
intervention terms could be applied to the original time series. All the analysis was conducted 
using SPSS (v.16) software. Costs were calculated in 2012-2013 Egyptian Pounds (L.E) and 
converted to US Dollars using the International Monetary Fund (IMF) Purchasing Power 
Parity (PPP) (using CCEMG – EPPI-Centre Cost Converter available at: 
http://eppi.ioe.ac.uk/costconversion/Default.aspx ) . 
Results 
Monthly and total annual inpatient utilisation and costs of IV paracetamol in the period from 
January 2012 to December 2013 are presented in Table 1.  
Insert Table 1 here 
Overall, the total annual utilisation of IV paracetamol was 34,572 ampoules in 2012, before 
the introduction of the intervention. The average monthly utilisation was 2,881 ampoules 
(95% CI: 2,807-2,955). This equates to a total cost of 674,154 L.E., with an average monthly 
cost of 56,180 L.E. (95% CI: 54,739 to 57,620 L.E.).  
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In 2013, following implementation, the total utilisation of IV paracetamol fell to 25,344 
ampoules with a monthly average of 2,111 (95% CI: 2068 to 2155). The total cost in 2013 
was 494,013 L.E. with a monthly average of 41,168 L.E. (95% CI: 40,317 to 42,018 L.E.).  
Thus, the reduction in monthly utilisation compared to pre-intervention values ranged from 
329 to 1,234 ampoules with an average of 770 ampoules (95% CI: 677 to 830). This 
reduction was highly statistically significant (p < 0.001). The monthly saving achieved, 
Figure 2, ranged from 6,416 to 24,063 L.E., with an average monthly saving of 15,012 L.E. 
(95% CI: 13,599 to 16,464 L.E., p < 0.001). These data showed that the relative reduction in 
monthly utilization and costs ranged from 14% to 39% with an average of 26% (95% CI: 
24% to 28%, p < 0.001).  
Insert Figure 2 here 
Using the Interrupted Time Series analysis, to adjust for the level of change observed in the 
pre-intervention period, it was estimated that before the intervention there was a downward 
trend with a decrease of 32 units per month; however, this was not statistically significant (p 
= 0.056) (Table 2). Similarly, there was an average decrease in monthly cost by 632 
L.E.($222), which was not statistically significant (p = 0.067) (Table 2). After the 
implementation of the intervention, in January 2013, there was an immediate change in the 
average monthly utilisation and costs and a trend change was observed over the whole follow 
up period.  
In the first month, upon the introduction of the intervention, there was a statistically 
significant reduction in utilisation (p = 0.001) and costs (p = 0.003) compared with the pre-
intervention period. The initial effect of the intervention decreased with time (months 1 to 5). 
After month 5, the reduction was still evident in absolute and relative terms but not 
statistically different from the pre-intervention period for both monthly utilisation (p = 0.07) 
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and costs (p = 0.071). Figure 3 shows the time series for IV paracetamol utilisation before 
and after the implementation of the intervention (the time series for costs, not shown, is a 
linear function of utilisation). This suggests that the intervention effect was sustained for the 
first 5 months of implementation but its effect was attenuated after this period. 
Insert Table 2 here 
Insert Figure 3 here 
The total number of admissions to the hospital was 10,682 in 2012 (before the introduction of 
the intervention) and 10,982 in 2013 (following the introduction of the intervention). The 
average monthly number of admissions was 890 (SD = 53) in 2012 and 915 (SD = 55) in 
2013. The difference in the mean number of admissions between the two years was not 
statistically significant (p = 0.27). 
Discussion 
The results of this study showed that, a multifaceted, protocol-based intervention 
implemented at a general hospital achieved a significant reduction in the utilisation and cost 
of IV paracetamol. The effect was statistically significant, showing a significant discontinuity 
in the utilisation and costs of IV paracetamol immediately after its implementation and a 
sustained effect for the first 5 months. In absolute terms, this reduction continued over the 
study period. Adjusting for the pre-intervention trend showed that after 5 months the change 
in the rate of reduction in utilisation was not statistically significant compared with the pre-
intervention trend.  
Pain management in hospitalised patients is a necessary skill set for all physicians. Pain is so 
pervasive in the hospital setting that it is sometimes referred to as “the fifth vital sign,” and 
failure to manage pain has important implications not only for physicians, but also for the 
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hospitals where they practice [18]. The World Health Organization (WHO) reports that the 
irrational use of medicines is a major problem worldwide [19]. The over-use of parenteral 
formulations, while oral formulations would be as appropriate, is one of the key factors 
contributing to the irrational use of medicines and unnecessary increase in drug spending 
[20]. IV-to-PO switching within an appropriate time postoperatively is one of the major areas 
that could be targeted to rationalise the use of parenteral forms [21].  Thus, the results of this 
study have relevance internationally to help ease the burden on already stretched resources.  
The cost of IV paracetamol is several times higher compared to the oral form (0.05 L.E. 
($0.02) per 100 mg for the oral vs 1.95 L.E. ($6.85) per 100 mg for the IV preparation), this 
would not stop physicians from prescribing the IV formulation in Egypt. However, adherence 
to guidelines regarding early switching from IV to oral therapy in Egypt is still not 
appropriate. The lack of computerized prescribing systems is a major contributing factor to 
this low level of adherence [22]. However, this poor adherence is a problem also in other 
developed countries (e.g. the United Kingdom) [23]. 
In the context of postoperative pain management, the use of the IV route is clinically justified 
where there is an urgent need to treat pain and/or when other routes of administration are not 
possible [24]. However, the IV route may not always be used appropriately and can be 
associated with potential problems such as: associated risks of infection; local pain and 
inflammation; possible overdose with concomitant oral medicines containing paracetamol, 
especially in patients with hepatic impairment or severe renal impairment; failure to adjust 
the dose according to body weight or other patient-related factors. These issues may lead to a 
considerable increase in nursing time and costs [7,24].  Hence, the recommendation is to 
switch to the oral route as soon as this becomes possible. Adhering to this evidence-based 
prescribing practice has proven to be cost-effective; achieving positive outcomes in terms of 
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reduced risk of infection and hospital length of stay while reducing the costs associated with 
IV paracetamol use [7]. The effect of such adherence was evident in this intervention study as 
well, where a significant reduction in utilisation and costs was achievable without adversely 
affecting the level of postoperative pain management, where patient-requested analgesics’ 
utilisation levels remained stable over the two-year study period. 
Previous studies that examined the effectiveness of interventions to promote IV- to Oral 
switching for paracetamol, PPIs and antibiotics have shown similar results, with an initially 
significant change in physicians’ prescribing behavior, which tended to level off [7,8,25,26]. 
A systematic review of the effectiveness of similar interventions to improve antibiotic 
prescribing in hospitals included studies of interventions directed to changing the route of 
administration [27]. The review concluded that restrictive interventions, such as automatic 
stop orders similar to the intervention used in this study, had a significantly greater impact on 
prescribing outcomes in the short-run (6 months) but not in the long-run (12 and 24 months) 
when compared to persuasive interventions [27]. This trend suggests that there may be a need 
for follow-up measures and continuous education to maintain the achieved change. However, 
overall, the average level of change seen in this study (26% reduction in utilisation of IV 
paracetamol) was found to be within the range reported in this Cochrane review when using 
primarily restrictive interventions (17% to 34% in the desired direction) [27]. It is also likely 
that the level of utilization may have reached an optimum level, with no further room for 
improvement. 
The use of ITS analysis can be a particularly useful method in prescribing research to allow 
the analysis of drug prescribing and utilisation levels and trends. It can be a powerful tool for 
hospital pharmacies to track and identify challenging and non-evidence based prescribing 
practices that require remedial action. It has been used to assess the effectiveness of 
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interventions to improve prescribing of various medications including antidepressants, 
antibiotics and proton pump inhibitors [8,28,29]. The implementation of a computer 
physician order entry (CPOE) system can further enhance the usability of this method and 
simplify the data collection. A CPOE system would also make it possible to design 
interventions based on sending computerised reminders to prescribers in addition to 
facilitating the collection of real-time data for audit and research purposes [13]. 
There are a number of limitations to our study. Firstly, it was conducted at a single hospital in 
a large city and consequently the findings may not be generalisable to other settings. 
Secondly, the study focused on assessing changes in process measures on a whole hospital 
level rather than clinical outcomes on an individual patient level. Finally, the results may 
have been confounded by other factors such as the case mix; given the quasi-experimental 
before-and-after research design. Nevertheless, and despite these limitations, the study 
showed that this protocol-based intervention has achieved considerable efficiency saving in a 
resource-limited setting. Reinforcing the messages delivered through the implementation 
activities on a bi-annual basis can further improve the outcomes and ensure maintenance of a 
positive effect. Further research should focus on assessing patient-level, clinical outcomes as 
part of a full pharmacoeconomic evaluation to assess the cost effectiveness of this 
intervention.  
In conclusion, the implementation of a protocol-based intervention to achieve a timely switch 
from IV to oral paracetamol in the context of postoperative pain management achieved an 
immediate significant reduction in the utilisation and cost of IV paracetamol. However, as 
with other interventions aimed at changing prescribing behaviour, this effect may require 
additional measures to be sustainable. Choosing the appropriate administration route is an 
important step in the prescribing process that can optimise patient outcomes in a cost-
effective manner.  
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Figure legends: 
 
Figure 1: Flow chart illustrating the steps involved in the protocol-based process and the 
criteria for dispensing IV paracetamol 
 
Figure 2: Monthly IV paracetamol cost saving achieved following the implementation of the 
intervention. 
Figure 3: Time series of monthly IV paracetamol utilisation before and after the 
implementation of the protocol-based intervention. 
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Tables 
Table 1: Monthly IV paracetamol utilisation and associated costs over the study period 
(January 2012 to December 2013) 
Month Units (100 mg single use ampoule) Costs (L.E.)* 
2012 2013 2012 2013 
January  2996 2045 58,422 39,878 
February  2605 1994 50,798 38,883 
March  3073 2149 59,924 41,906 
April  3067 2128 59,807 41,496 
May  2986 2005 58,227 39,098 
June  3248 2305 63,336 44,948 
July  3152 1918 61,464 37,401 
August 2752 2301 53,664 44,870 
September 2925 2345 57,038 45,728 
October 2428 2099 47,346 40,931 
November 2839 2179 55,361 42,491 
December 2501 1866 48,770 36,387 
Total 34572 25344 674,154 494,013 
* IV paracetamol unit cost = 19.5 L.E. 
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Table 2: Summary of the AutoRegressive, Integrated, Moving Average (ARIMA) model 
analysis showing the estimated reduction in IV paracetamol utilisation and costs 
following intervention implementation compared with pre-intervention levels. 
Time after 
introducing 
intervention 
(months) 
Change in utilisation (units) Change in cost (L.E.) 
Mean  
(95% CI) 
P-value 
Mean  
(95% CI) 
P-value 
0 (pre-intervention) 
-32 (-66, 2) 0.056 -6,32(-1,342, 78) 0.067 
1 
-636 (-985, -287) 0.001* -11,418 (-18,575, -4,261) 0.003* 
2 
-585(-938, -233) 0.002* -10,695 (-1,7966, -3,424 0.005* 
3 
-534 (-897, -171) 0.005* -9,972 (-1,7489, -2,455) 0.009* 
4 
-484 (-864, -103) 0.013* -9,248 (-17,127, -1,369) 0.019* 
5 
-433 (-836, -29) 0.031* -8,525 (-16,870, -180)        0.038* 
6 
-382 (-813, 49) 0.070 -7,802 (-16,700, 1,096)  0.071 
7 
-331(-794, 132) 0.137 -7,079 (-16,603, 2,445) 0.122 
8 
-280 (-778, 218) 0.237 -6,355 (-16,561, 3,851) 0.191 
9 
-229(-765, 307) 0.364 -5,632 (-16,570, 5,306) 0.276 
10 
-178 (-754, 398) 0.509 -4,909 (-16,616, 6,798) 0.372 
11 
-127 (-744, 490) 0.659 -4,186 (-16,695, 8,323) 0.475 
12 
-76(-736, 584) 0.804 -3,463 (-16,802, 9,876)  0.578 
*Statistically significant (P < 0.05) 
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Ward pharmacist reviewed the availability of any of the set of criteria 
1. Surgical patients within 48 hr post-operative. 
2. NPO patients suffering from pain or patients with mucositis, 
3. Other pain patients only after the approval of DTC 
4. Acutely febrile (temperature > 38C) patients as PRN. If it is required to be given 
regular, one single dose of IV paracetamol to be prescribed followed by oral 
form 
IV paracetamol prescribed 
Criteria met 
Pharmacist dispenses it 
Criteria unmet 
Pharmacist contacts prescriber 
Prescriber changes to oral Prescriber Insists on 
intravenous 
Pharmacist stops dispensing 
Pharmacist contacts 
DTC chairman 
DTC chairman 
contacts prescriber 
Prescriber provides 
reasons for exception 
DTC approval 
Page 24 of 25Journal of Evaluation in Clinical Practice
For peer review only
0
5,000
10,000
15,000
20,000
25,000
IV
 p
a
ra
ce
ta
m
o
l 
co
st
 s
a
v
in
g
 (
L
.E
.)
Month
 
*
 IV paracetamol unit cost = 19.5 L.E. 
 
Page 25 of 25 Journal of Evaluation in Clinical Practice
For peer review only
0
500
1000
1500
2000
2500
3000
3500
Ja
n
u
a
ry
 2
0
1
2
F
e
b
ru
a
ry
 2
0
1
2
M
a
rc
h
 2
0
1
2
A
p
ri
l 
2
0
1
2
M
a
y
 2
0
1
2
Ju
n
e
 2
0
1
2
Ju
ly
 2
0
1
2
A
u
g
u
st
 2
0
1
2
S
e
p
te
m
b
e
r 
2
0
1
2
O
ct
o
b
e
r 
2
0
1
2
N
o
v
e
m
b
e
r 
2
0
1
2
D
e
ce
m
b
e
r 
2
0
1
2
Ja
n
u
a
ry
 2
0
1
3
F
e
b
ru
a
ry
 2
0
1
3
M
a
rc
h
 2
0
1
3
A
p
ri
l 
2
0
1
3
M
a
y
 2
0
1
3
Ju
n
e
 2
0
1
3
Ju
ly
 2
0
1
3
A
u
g
u
st
 2
0
1
3
S
e
p
te
m
b
e
r 
2
0
1
3
O
ct
o
b
e
r 
2
0
1
3
N
o
v
e
m
b
e
r 
2
0
1
3
D
e
ce
m
b
e
r 
2
0
1
3
N
u
m
b
e
r 
o
f 
d
is
p
e
n
se
d
 I
V
 p
a
ra
ce
ta
m
o
l 
a
m
p
o
u
le
s 
Intervention implemented
 
 
Page 26 of 25Journal of Evaluation in Clinical Practice
